Fiona Shand
TitleCited byYear
Treatment approaches for alcohol and drug dependence: An introductory guide
TJ Jarvis, J Tebbutt, RP Mattick, F Shand
Wiley, 2005
Sex differences amongst dependent heroin users: histories, clinical characteristics and predictors of other substance dependence
FL Shand, L Degenhardt, T Slade, EC Nelson
Addictive behaviors 36 (1-2), 27-36, 2011
Guidelines for the treatment of alcohol problems
FL Shand
Department of Health and Ageing, 2003
Persistence of preference for a flavor presented in simultaneous compound with sucrose.
JA Harris, FL Shand, LQ Carroll, RF Westbrook
Journal of Experimental Psychology: Animal Behavior Processes 30 (3), 177, 2004
The treatment of alcohol problems: A review of the evidence
F Shand, J Gates, J Fawcett, R Mattick
Sydney: National Drug and Alcohol Research Centre, 2003
Evidence of CNIH3 involvement in opioid dependence
EC Nelson, A Agrawal, AC Heath, R Bogdan, R Sherva, B Zhang, ...
Molecular psychiatry 21 (5), 608-614, 2016
The effectiveness of a suicide prevention app for indigenous Australian youths: study protocol for a randomized controlled trial
FL Shand, R Ridani, J Tighe, H Christensen
Trials 14 (1), 396, 2013
Road to resilience: a systematic review and meta-analysis of resilience training programmes and interventions
S Joyce, F Shand, J Tighe, SJ Laurent, RA Bryant, SB Harvey
BMJ open 8 (6), e017858, 2018
ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure
EC Nelson, MT Lynskey, AC Heath, N Wray, A Agrawal, FL Shand, ...
JAMA psychiatry 70 (3), 325-333, 2013
ANKK1, TTC12, and NCAM1 Polymorphisms and Heroin DependenceImportance of Considering Drug ExposureANKK1, TTC12, and NCAM1 Polymorphisms and Heroin
EC Nelson, MT Lynskey, AC Heath, N Wray, A Agrawal, FL Shand, ...
JAMA Psychiatry 70 (3), 325-333, 2013
Association of OPRD1 polymorphisms with heroin dependence in a large case‐control series
EC Nelson, MT Lynskey, AC Heath, N Wray, A Agrawal, FL Shand, ...
Addiction Biology, 2012
The monitoring of drug trends in Australia
F Shand, L Topp, S Darke, T Makkai, P Griffiths
Drug and Alcohol Review 22 (1), 61-72, 2003
Best strategies for reducing the suicide rate in Australia
K Krysinska, PJ Batterham, M Tye, F Shand, AL Calear, N Cockayne, ...
Australian & New Zealand Journal of Psychiatry 50 (2), 115-118, 2016
Ibobbly mobile health intervention for suicide prevention in Australian Indigenous youth: a pilot randomised controlled trial
J Tighe, F Shand, R Ridani, A Mackinnon, N De La Mata, H Christensen
BMJ open 7 (1), 2017
What interrupts suicide attempts in men: a qualitative study
MJ Player, J Proudfoot, A Fogarty, E Whittle, M Spurrier, F Shand, ...
PLoS One 10 (6), 2015
The effect of comorbid substance use disorders on treatment outcome for anxiety disorders
PM McEvoy, F Shand
Journal of anxiety disorders 22 (6), 1087-1098, 2008
Real-time monitoring of Schedule 8 medicines in Australia: evaluation is essential
FL Shand, G Campbell, W Hall, N Lintzeris, M Cohen, L Degenhardt
The Medical Journal of Australia 198 (2), 80-81, 2013
Clients of treatment service agencies: May 2001 census findings
FL Shand, RP Mattick
Department of Health and Ageing, 2001
Suicide prevention in Australian Aboriginal communities: a review of past and present programs
R Ridani, FL Shand, H Christensen, K McKay, J Tighe, J Burns, E Hunter
Suicide and life-threatening behavior 45 (1), 111-140, 2015
Cohort protocol paper: The Pain and Opioids In Treatment (POINT) study
G Campbell, R Mattick, R Bruno, B Larance, S Nielsen, M Cohen, ...
BMC Pharmacology and Toxicology 15 (1), 17, 2014
The system can't perform the operation now. Try again later.
Articles 1–20